Cetuximab in Previously Treated Colorectal Cancer
- 1 April 2005
- journal article
- review article
- Published by Elsevier in Clinical Colorectal Cancer
- Vol. 5, S28-S33
- https://doi.org/10.3816/ccc.2005.s.004
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Signal transduction and oncogenesis by ErbB/HER receptorsInternational Journal of Radiation Oncology*Biology*Physics, 2004
- FOLFIRI Followed by FOLFOX6 or the Reverse Sequence in Advanced Colorectal Cancer: A Randomized GERCOR StudyJournal of Clinical Oncology, 2004
- A Randomized Controlled Trial of Fluorouracil Plus Leucovorin, Irinotecan, and Oxaliplatin Combinations in Patients With Previously Untreated Metastatic Colorectal CancerJournal of Clinical Oncology, 2004
- Targeting HER1/EGFR: A molecular approach to cancer therapySeminars in Oncology, 2003
- Crystal Structure of the Complex of Human Epidermal Growth Factor and Receptor Extracellular DomainsCell, 2002
- Untangling the ErbB signalling networkNature Reviews Molecular Cell Biology, 2001
- Expression of the Tyrosine Kinase Activity Growth Factor Receptors (EGFR, ERB B2, ERB B3) in Colorectal Adenocarcinomas and AdenomasTumor Biology, 2000
- EGF, TGF-a, and EGF-R in Human Colorectal AdenocarcinomaActa Oncologica, 1998
- Antitumor Effects of Doxorubicin in Combination With Anti-epidermal Growth Factor Receptor Monoclonal AntibodiesJNCI Journal of the National Cancer Institute, 1993
- The prognostic significance of proliferating cell nuclear antigen, epidermal growth factor receptor, andmdr gene expression in colorectal cancerCancer, 1993